Role	0	4	O
of	5	7	O
telomeres	8	17	O
in	18	20	O
vascular	21	29	O
senescence	30	40	O
.	40	41	O

Telomeres	43	52	O
are	53	56	O
DNA	57	60	O
regions	61	68	O
composed	69	77	O
of	78	80	O
TTAGGG	81	87	O
repeats	88	95	O
that	96	100	O
are	101	104	O
located	105	112	O
at	113	115	O
the	116	119	O
ends	120	124	O
of	125	127	O
chromosomes	128	139	B-Cellular_component
.	139	140	O

Specific	141	149	O
proteins	150	158	O
associate	159	168	O
with	169	173	O
the	174	177	O
telomeres	178	187	O
and	188	191	O
form	192	196	O
non	197	200	O
-	200	201	O
nucleosomal	201	212	O
DNA	213	216	O
-	216	217	O
protein	217	224	O
complexes	225	234	O
that	235	239	O
serve	240	245	O
as	246	248	O
protective	249	259	O
caps	260	264	O
for	265	268	O
the	269	272	O
chromosome	273	283	B-Cellular_component
ends	284	288	O
.	288	289	O

There	290	295	O
is	296	298	O
accumulating	299	311	O
evidence	312	320	O
that	321	325	O
progressive	326	337	O
telomere	338	346	O
shortening	347	357	O
is	358	360	O
closely	361	368	O
related	369	376	O
to	377	379	O
cardiovascular	380	394	O
disease	395	402	O
.	402	403	O

For	404	407	O
example	408	415	O
,	415	416	O
vascular	417	425	B-Cell
cell	426	430	I-Cell
senescence	431	441	O
has	442	445	O
been	446	450	O
reported	451	459	O
to	460	462	O
occur	463	468	O
in	469	471	O
human	472	477	B-Organism
atherosclerotic	478	493	B-Pathological_formation
lesions	494	501	I-Pathological_formation
and	502	505	O
this	506	510	O
change	511	517	O
is	518	520	O
associated	521	531	O
with	532	536	O
telomere	537	545	O
shortening	546	556	O
.	556	557	O

Impairment	558	568	O
of	569	571	O
telomere	572	580	O
integrity	581	590	O
causes	591	597	O
vascular	598	606	B-Multi-tissue_structure
dysfunction	607	618	O
,	618	619	O
which	620	625	O
is	626	628	O
prevented	629	638	O
by	639	641	O
the	642	645	O
activation	646	656	O
of	657	659	O
telomerase	660	670	B-Gene_or_gene_product
.	670	671	O

Mice	672	676	B-Organism
with	677	681	O
short	682	687	O
telomeres	688	697	O
develop	698	705	O
hypertension	706	718	O
and	719	722	O
exhibit	723	730	O
impaired	731	739	O
neovascularization	740	758	O
.	758	759	O

Short	760	765	O
telomeres	766	775	O
have	776	780	O
also	781	785	O
been	786	790	O
reported	791	799	O
in	800	802	O
the	803	806	O
leukocytes	807	817	B-Cell
of	818	820	O
patients	821	829	B-Organism
with	830	834	O
cardiovascular	835	849	O
disease	850	857	O
or	858	860	O
various	861	868	O
cardiovascular	869	883	O
risk	884	888	O
factors	889	896	O
.	896	897	O

Although	898	906	O
it	907	909	O
remains	910	917	O
unclear	918	925	O
whether	926	933	O
short	934	939	O
telomeres	940	949	O
directly	950	958	O
cause	959	964	O
cardiovascular	965	979	O
disease	980	987	O
,	987	988	O
manipulation	989	1001	O
of	1002	1004	O
telomere	1005	1013	O
function	1014	1022	O
is	1023	1025	O
potentially	1026	1037	O
an	1038	1040	O
attractive	1041	1051	O
strategy	1052	1060	O
for	1061	1064	O
the	1065	1068	O
treatment	1069	1078	O
of	1079	1081	O
vascular	1082	1090	O
senescence	1091	1101	O
.	1101	1102	O

